ECG Electrode

Ianuali 24, 2022 8:00 pm ET |Puna: DelveInsight Business Research LLP DelveInsight Business Research LLP
LOS ANGELES, USA, Jan 24, 2022 (GLOBE NEWSWIRE) - Manaʻo ʻia ka mākeke mākaʻi ECG e ulu i kahi CAGR nui o 5.73% a hiki i $ 5.87B e 2026, ʻōlelo ʻo DelveInsight.
Manaʻo ka mākeke no nā mea nānā ECG e ulu i nā makahiki e hiki mai ana ma muli o nā kumu e like me ka piʻi ʻana o ka ulu ʻana o nā maʻi cardiovascular a me ka piʻi ʻana o ka ulu ʻana o ka puʻuwai puʻuwai, e alakaʻi i ka piʻi ʻana o ka noi no nā mea nānā ECG. , ma laila e hoʻoulu ai i ka ulu ʻana o nā mea nānā ECG..makeke.
ʻO ka DelveInsight ECG Monitoring Devices Market Status and Forecast hōʻike i kēia manawa a me ka wānana i nā polokalamu nānā ECG, nā mea hou e hiki mai ana, nā māhele mākeke o kēlā me kēia kanaka, nā pilikia, nā mea hoʻokele a me nā mea pale, nā ʻano mākeke a me nā mea hoʻokūkū kiʻekiʻe i ka wahi o ka nānā ʻana o ka ECG..
E kiʻi i ka nūhou hou e pili ana i ka mākeke mīkini nānā ECG.E kiʻi i kahi ʻike o nā mea koʻikoʻi i hoʻokomo ʻia i ka hōʻike mākeke ECG Monitoring Devices.
ʻO kahi mea nānā electrocardiogram (ECG) kahi mea kōkua e hoʻopaʻa i nā hōʻailona uila mai ka puʻuwai.He ho'āʻo maʻamau a ʻeha ʻole kēia i hoʻohana ʻia e ana i nā pilikia o ka naʻau a nānā i ke olakino naʻau.ʻO ka electrocardiogram kahi mea ʻeha ʻole, ʻaʻohe invasive i hoʻohana ʻia e ʻike i nā pilikia o ka naʻau maʻamau i kēlā me kēia makahiki, e like me ka arrhythmias abnormal, ka maʻi coronary artery, a me nā mea hou aku.Pono ʻia kahi ECG no nā pilikia like ʻole, e like me ka ʻeha o ka umauma, dizziness, lightheadedness or confusion, heart palpitations, a me nā mea hou aku.
Makemake ʻoe e ʻike pehea e ulu ai nā lako kiaʻi ECG i ka makahiki 2026? Kaomi no ka loaʻa ʻana o kahi hōʻike kikoʻī o ka mākaʻikaʻi mākeke ECG.
ʻO Geographically, ke ʻimi ʻia nei ka mākeke mākaʻi ECG honua no ʻAmelika ʻAmelika, ʻEulopa, Asia Pacific, a me ke koena o ka honua.I ka ʻōlelo o ka loaʻa kālā, alakaʻi maʻamau ʻo ʻAmelika ʻĀkau i ka mākeke honua i kēia manawa a ke manaʻo nei e hoʻomau i ka hana i ka wā wānana.Eia nō naʻe, e hoʻohālikelike ka mākeke ʻEulopa i ka mana o ka mākeke ʻAmelika ʻAmelika.ʻO kēia mana ma muli o ka piʻi nui ʻana o ka maʻi cardiovascular, nā kulekele hoihoi hou a me ka hele ʻana o nā mea pāʻani koʻikoʻi āpau i ka mākeke ʻAmelika ʻAmelika.
No ka laʻana, i Iulai 2021, hoʻolaha ʻo EchoNous, he alakaʻi i nā mea kani ultrasound ultra-portable a me nā polokalamu akamai artificial (POCUS), i ka hui pū ʻana me ka mea hoʻomohala aʻo mīkini ma Singapore ʻo Us2.ai e hoʻomaʻamaʻa i ka echocardiogram analysis Graphics and ana software driver.
Ma Mei 6, 2020, ua loaʻa ʻo LifeSignals i ka ʻae ʻia ʻo CE Mark no ka ECG Remote Monitoring Patch, kahi ʻōnaehana nānā mamao uila hoʻokahi manawa no ka hōʻiliʻili ECG mau a me ka nānā ʻana i ka puʻuwai puʻuwai.
E aʻo hou aʻe e pili ana i ka mākeke mea hoʻokele ECG @ ECG mākaʻikaʻi mākaʻikaʻi mākeke loiloi
E ulu aʻe ka noi no nā mea nānā ECG ma muli o kekahi mau mea e like me ka piʻi ʻana o ka maʻi cardiovascular, ka piʻi ʻana o ka puʻuwai puʻuwai a me ka hele ʻana o nā mea pāʻani nui āpau i ka mākeke hāmeʻa ECG.Ma waho aʻe o kēia, ma muli o ka hoʻonui ʻia o ka hoʻohana ʻana i nā lako nānā ECG ma waena o nā mea maʻi a me nā hiʻohiʻona ʻenehana o nā lako nānā ECG e like me nā ʻōnaehana pale paʻi, ka hoʻohui ʻana o nā ʻōnaehana hoʻokele ECG, nā moʻolelo olakino uila (EMR) a me nā ʻōnaehana ʻike cardiovascular (CVIS). ) Hoʻohui maikaʻi aʻe) ke alakaʻi nei i ka ulu ʻana o ka mākeke mākaʻi ECG holoʻokoʻa.Eia kekahi, ʻike ka mākeke mākaʻikaʻi ECG i ka ulu nui i ka wā wānana ma muli o nā kulekele hoʻihoʻi maikaʻi o ke kumukūʻai, nā hoʻolauna ʻana o nā mea hou, ka ulu ʻana o ka mākeke e pili ana i nā huahana, a me nā hui a me nā loaʻa.
Ma ka hoʻohālikelike ʻana, ua hoʻopilikia nui ʻia ka mākeke mākaʻi ECG e ka maʻi maʻi COVID-19.Ma muli o ke kūlana o ka maʻi maʻi maʻi COVID-19, ua hoʻokuʻu ʻia nā ʻano kaʻina hana koho ʻē aʻe āpau a hāʻawi ʻia nā mea maʻi i hoʻopilikia ʻia e COVID-19 i ka mea nui loa.Eia nō naʻe, loaʻa i nā mea maʻi me COVID-19 nā maʻi ʻē aʻe, me ka maʻi cardiovascular, e koi ana i ka nānā mau ʻana i ka naʻau no ka maʻi cardiovascular a me nā arrhythmias.
No ka hoʻomaopopo maikaʻi ʻana i ka hopena o COVID-19 ma nā polokalamu nānā ECG, e kiʻi i kahi ʻike i ka hopena o ka wā e hiki mai ana o ka mākeke mākaʻi ECG.
ʻO nā mea hana nui o nā mea nānā ECG: General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips NV, Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation , LUMED SRL Sede Legale, iRhythm Technologies, Inc. a me nā mea ʻē aʻe he nui.
ʻIke ʻia ʻo Delveinsight: Ke manaʻo nei ka mākeke mākaʻi ECG e ulu i kahi CAGR o 5.73% a hiki i ka US $ 5.87 biliona e 2026.
E aʻo hou e pili ana i ka hōʻike "Medical Devices for the Diagnosis, Prevention and Treatment of Various Diseases" a me "Key Players Developing Multiple Devices to Drive the Therapeutic Market".
Manaʻo ʻia ka mākeke puʻuwai puʻuwai e ka huahana, ʻano, therapy, ka mea hoʻohana hope a me ka geography e ulu i ka helu CAGR mau.Hāʻawi ka hōʻike i ka ʻike hohonu o ka Heart Pumps a me ka mōʻaukala a me ka wānana ʻana i ka mākeke Heart Pump, nā mea hoʻokele mākeke, nā pale mākeke, a me nā hui nui e komo pū ana e like me Abbott, Abiomed, Teleflex Incorporated, Syncardia Systems, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc, Terumo Heart.
ʻO DelveInsight's Congestive Heart Failure Devices Market Status, Competitive Landscape and Market Forecast to 2026 hōʻike e hāʻawi i kahi ʻike hohonu o nā Congestive Heart Failure Devices a me ka Congestive Heart Failure Devices mākeke mōʻaukala a me nā ʻano wanana, nā mea hoʻokele mākeke, nā pale mākeke a me nā hui nui.ʻO nā lālā me Abiomed, Medtronic, Abbott, Berlin Heart GmbH, Boston Scientific, HeartWare International, LivaNova PLC, etc.
ʻO ka hōʻike ʻo DelveInsight "Transcatheter Devices for Heart Valve Replacement (THVR) Market Analysis, Competitive Landscape and Market Forecasts to 2026" hāʻawi i kahi kikoʻī kikoʻī o THVR a me ka mōʻaukala a me ka wānana i nā ʻano mākeke THVR, nā mea hoʻokele mākeke, nā pale mākeke a me nā hui nui e pili ana, e like me Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific, CryoLife Inc, etc.
Kuhi ʻia ka mākeke Auxiliary Mechanical Circulation Equipment e ka huahana, ka mea hoʻohana hope a me ka ʻāina ʻāina e ulu i ka helu CAGR paʻa a hiki i 2026. Hāʻawi ka hōʻike i kahi ʻike hohonu o nā Mechanical Circulatory Support Devices a me ka mōʻaukala a me ka wānana Mechanical Circulatory Support Devices market. nā ʻano, nā mea hoʻokele mākeke, nā pale mākeke, a me nā hui nui e pili ana e like me Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude.Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt.Ltd. etc.
ʻO ka DelveInsight Report, "Percutaneous Mechanical Circulatory Support Device Market Overview, Competitive Landscape, and Market Forecasts to 2026" hāʻawi i kahi kikoʻī kikoʻī o ka mākeke Percutaneous Mechanical Circulatory Support Device, a me ka mōʻaukala a me ka wānana o ka mākeke Percutaneous Mechanical Circulatory Support Device. , nā mea hoʻokele mākeke, nā pale mākeke a me ke komo ʻana o nā hui nui e like me Abbott, Medtronic, Getinge AB, Teleflex Incorporated, LivanovaPlc (Cardiacassist, Inc.), Abiomed, Euroset, Berlin Heart, Jarvik Heart, CardioBridge GmbH, etc.
ʻO DelveInsight kahi hui kūkākūkā ʻoihana alakaʻi a me ka ʻoihana noiʻi mākeke i ka ʻepekema ola.Kākoʻo ia i nā hui lāʻau lapaʻau ma o ka hāʻawi ʻana i nā hopena hopena i ka hopena e hoʻomaikaʻi i kā lākou huahana.E komo maʻalahi i nā hōʻike noiʻi noiʻi olakino olakino a me nā lāʻau lapaʻau ma o kā mākou papa inoa ʻo PharmDelve.